Skip to main content

Table 1 Patient characteristics

From: Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)

 

DHEA

Controls

P-value

Number

22

44

 

Age (years, Mean ± SD)

37.9 ± 4.7

37.2 ± 4.4

N.S.

Race/ethnicity (%)

   

Caucasian

14 (63.6)

21 (47.7)

 

African

2 (9.1)

3 (6.8)

 

Asian

4 (18.2)

14 (31.8)

 

Middle Eastern

1 (4.5)

6 (13.6)

 

BMI (Mean ± SD)

24.4 ± 3.8

21.0 ± 1.7

0.006

AMH (ng/mL, mean ± SD)

1.3 ± 1.2

2.0 ± 1.9

0.045

Range

0.8 - 2.1

1.0 - 4.4

 

FSH (mIU/mL, mean ± SD)

10.1 ± 6.8

8.0 ± 5.5

N.S.

Range

8.4 - 12.2

7.1 - 9.1

 

Oocytes retrieved (n, mean ± SD)

9.6 ± 6.2

11.7 ± 6.3

N.S.

Embryos (n, mean ± SD)

   

Transferred

1.4 ± 0.9

1.5 ± 0.7

 

Cryopreserved

0.7 ± 1.6

0.6 ± 1.2

 

Undergoing PGS

7.3 ± 3.9

6.6 ± 3.6

 

Grades

3.4 ± 0.4

3.5 ± 0.3

 

Total gonadotropins dosage (IU, mean ± SD)

5711 ± 1818

4048 ± 1886

0.002

  1. 1 Difference in BMI was based on significant difference in weight (P = 0.02) not height (P = 0.24)